SLCO1B1 and Hepatic fibrosis: Thus, the differences in the serum ASV concentrations depending on the severity of liver fibrosis should be evaluated in the future in reference to UGT1A1 SNPs and hepatic mRNA expressions of CYP3A4 and OATP1B1.